Leanne M. Kelly's most recent trade in GRI Bio Inc was a trade of 11,854 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
GRI Bio Inc | Leanne M. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2025 | 11,854 | 11,854 | - | - | Stock Option (Right to Buy) | |
GRI Bio Inc | Leanne M. Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 43,319 | 43,319 | - | - | Stock Option (Right to Buy) |